Bangladesh signed a deal with the Serum Institute of India on Thursday to buy 30 million doses of a potential coronavirus vaccine being developed by British drugmaker AstraZeneca.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback